HSV Update
Subscribe to receive The HSV Update newsletter
23 December 2021
Up-classification of surgical mesh devices
The Therapeutic Goods Administration (TGA) has recently up-classified implantable surgical mesh devices from Class IIb (medium-risk devices) to Class III (high-risk devices).
Read More Up-classification of surgical mesh devices
22 December 2021
HSV opens Victoria’s largest warehouse for public health goods
HealthShare Victoria’s (HSV’s) new Derrimut Distribution Centre (DC) is stocked with more than 2,000 medical and health related goods for our first health service customers from the Royal Melbourne Hospital group.
Read More HSV opens Victoria’s largest warehouse for public health goods
22 December 2021
Health sector engagement key to procurement planning
HSV’s first Procurement Activity Plan (PAP) review (FY22:H2) includes 71 activities with a target delivery of $310 million to 2025.
Read More Health sector engagement key to procurement planning
22 December 2021
New contract to reduce Rapid Antigen Test costs for health services
HealthShare Victoria (HSV) has worked with the Department of Health (DH) and the Department of Treasury and Finance (DTF) for the statewide supply of Rapid Antigen Test (RAT) kits via a contract in place from 1 December 2021, with eight suppliers awarded, including one Australian company.
Read More New contract to reduce Rapid Antigen Test costs for health services